NAD+激酶
内质网
免疫电镜
高尔基体
癌细胞
线粒体
胞浆
化学
分子生物学
生物化学
生物
细胞生物学
癌症
酶
免疫学
免疫组织化学
遗传学
作者
Shannon L. Winski,Yiannis Koutalos,David L Bentley,David Ross
出处
期刊:PubMed
[National Institutes of Health]
日期:2002-03-01
卷期号:62 (5): 1420-1424
被引量:123
摘要
NAD(P)H:quinone oxidoreductase 1 (NQO1) is implicated in both chemoprevention and bioactivation of DNA-damaging antitumor agents. NQO1 is mainly cytosolic, but distribution in other cellular compartments, particularly in tumor cells, is poorly defined. Nuclear NQO1 in HT29 human colon carcinoma and H661 human non-small cell lung cancer cells was observed using both confocal microscopy and immunoelectron microscopy. NQO1 was not detected in mitochondria, golgi, or endoplasmic reticulum. In addition, purified intact nuclei from HT29 cells contained immunoreactive NQO1, which was catalytically active as determined by conventional activity assay. In summary, we have confirmed the presence of nuclear NQO1, which has implications for chemoprotection and bioactivation of DNA-damaging antitumor agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI